"Global Adult Vaccine Market Overview:
Global Adult Vaccine Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Adult Vaccine Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Adult Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Adult Vaccine Market:
The Adult Vaccine Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Adult Vaccine Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Adult Vaccine Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Adult Vaccine market has been segmented into:
Varicella
Influenza & Human Papillomavirus
By Application, Adult Vaccine market has been segmented into:
Monovalent Vaccines
Multivalent Vaccines
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Adult Vaccine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Adult Vaccine market.
Top Key Players Covered in Adult Vaccine market are:
Solvay Pharmaceuticals
Moderna
BioCSL (Seqirus)
Aventis Pasteur
Sanofi Pasteur
Pfizer Inc.
Merck & Co. Inc.
GlaxoSmithKline Plc
Novartis AG
Johnson & Johnson
BioNTech
Bharat Biotech International Limited
Zhifei
Wyeth Vaccines
AstraZeneca Plc
Medimmune
Sinovac
Baxter International Healthcare Company
Chiron Vaccines
Serum Institute of India
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Adult Vaccine Market by Type
4.1 Adult Vaccine Market Snapshot and Growth Engine
4.2 Adult Vaccine Market Overview
4.3 Varicella
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Varicella: Geographic Segmentation Analysis
4.4 Influenza & Human Papillomavirus
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Influenza & Human Papillomavirus: Geographic Segmentation Analysis
Chapter 5: Adult Vaccine Market by Application
5.1 Adult Vaccine Market Snapshot and Growth Engine
5.2 Adult Vaccine Market Overview
5.3 Monovalent Vaccines
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Monovalent Vaccines: Geographic Segmentation Analysis
5.4 Multivalent Vaccines
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Multivalent Vaccines: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Adult Vaccine Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 SOLVAY PHARMACEUTICALS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 MODERNA
6.4 BIOCSL (SEQIRUS)
6.5 AVENTIS PASTEUR
6.6 SANOFI PASTEUR
6.7 PFIZER INC.
6.8 MERCK & CO. INC.
6.9 GLAXOSMITHKLINE PLC
6.10 NOVARTIS AG
6.11 JOHNSON & JOHNSON
6.12 BIONTECH
6.13 BHARAT BIOTECH INTERNATIONAL LIMITED
6.14 ZHIFEI
6.15 WYETH VACCINES
6.16 ASTRAZENECA PLC
6.17 MEDIMMUNE
6.18 SINOVAC
6.19 BAXTER INTERNATIONAL HEALTHCARE COMPANY
6.20 CHIRON VACCINES
6.21 SERUM INSTITUTE OF INDIA
Chapter 7: Global Adult Vaccine Market By Region
7.1 Overview
7.2. North America Adult Vaccine Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Varicella
7.2.4.2 Influenza & Human Papillomavirus
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Monovalent Vaccines
7.2.5.2 Multivalent Vaccines
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Adult Vaccine Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Varicella
7.3.4.2 Influenza & Human Papillomavirus
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Monovalent Vaccines
7.3.5.2 Multivalent Vaccines
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Adult Vaccine Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Varicella
7.4.4.2 Influenza & Human Papillomavirus
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Monovalent Vaccines
7.4.5.2 Multivalent Vaccines
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Adult Vaccine Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Varicella
7.5.4.2 Influenza & Human Papillomavirus
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Monovalent Vaccines
7.5.5.2 Multivalent Vaccines
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Adult Vaccine Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Varicella
7.6.4.2 Influenza & Human Papillomavirus
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Monovalent Vaccines
7.6.5.2 Multivalent Vaccines
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Adult Vaccine Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Varicella
7.7.4.2 Influenza & Human Papillomavirus
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Monovalent Vaccines
7.7.5.2 Multivalent Vaccines
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Adult Vaccine Scope:
|
Report Data
|
Adult Vaccine Market
|
|
Adult Vaccine Market Size in 2025
|
USD XX million
|
|
Adult Vaccine CAGR 2025 - 2032
|
XX%
|
|
Adult Vaccine Base Year
|
2024
|
|
Adult Vaccine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Solvay Pharmaceuticals, Moderna, BioCSL (Seqirus), Aventis Pasteur, Sanofi Pasteur, Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline Plc, Novartis AG, Johnson & Johnson, BioNTech, Bharat Biotech International Limited, Zhifei, Wyeth Vaccines, AstraZeneca Plc, Medimmune, Sinovac, Baxter International Healthcare Company, Chiron Vaccines, Serum Institute of India.
|
|
Key Segments
|
By Type
Varicella
Influenza & Human Papillomavirus
By Applications
Monovalent Vaccines
Multivalent Vaccines
|
